Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM
Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics of Saxagliptin, 5-hydroxy
Saxagliptin, and Metformin in pediatric subjects with Type 2 diabetes mellitus (T2DM)
following oral administration of Saxagliptin and Metformin XR fixed dose combination tablet
and co-administration of Saxagliptin and Glucophage® (Metformin) IR tablets